This report on the regulatory affairs outsourcing market studies the current as well as future prospects of the market globally. Regulatory affairs outsourcing is rapidly gaining popularity in the global outsourcing market. Pharmaceutical, life science and medical device manufacturing companies are in constant collaboration with various outsourcing companies to get their drugs/devices approved and/or launched in the global market. These regulatory affairs service providers also provide other important services such as pharmacovigilance, medical writing and clinical trial services to pharma, biotech and medical device companies.
Browse the Regulatory Affairs Outsourcing Market Research Report with complete TOC at http://www.transparencymarketresearch.com/global-regulatory-affairs-outsourcing-market.html
Presently, these regulatory service providers help these companies to get quick and timely approval/launch of their products with several other advantages such as reduced cost, more time for organization’s staff toward core activities and easy penetration in other countries. This report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global regulatory affairs outsourcing market with respect to market segments based on the type of regulatory service provided and their geographic regions.
The regulatory affairs outsourcing market has been segmented into five major service segments: regulatory affairs; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation; and others. The market segments have been extensively analyzed on the basis of their usefulness, efficacy, generated revenue and geographic coverage. The market size and forecast in terms of USD million for each service type has been provided for the period from 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020.
Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3528
Geographically, the regulatory affairs outsourcing services market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions has been provided for the period from 2012 to 2020, along with their respective CAGRs for the forecast period from 2014 to 2020, considering 2013 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s five forces analysis and the key players’ market share analysis in 2013 in order to present a thorough analysis of the overall competitive scenario in the global regulatory affairs outsourcing market.
Browse More Medical Devices Related Research Reports athttp://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market and increase market share. The report also profiles major players of the regulatory affairs outsourcing market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Quintiles Transnational Holdings, Inc., Covance, Inc., Pharmaceutical Product Development, LLC, PAREXEL International Corporation, ICON plc, Charles River Laboratories International, Inc., WuXi AppTec, Criterium, Inc., Medpace, Inc., Promedica International, Accell Clinical Research, LLC, Clinilabs, Inc. and PRA International,